कैसे स्लीप नंबर के $1.5B बायबैक ने कंपनी को खत्म कर दिया

मूल अंग्रेज़ी प्रतिलेख। शीर्षक, सारांश और सामान्य प्रश्न अनुवादित हैं। पूर्ण कथन YouTube उपशीर्षकों के माध्यम से आपकी भाषा में उपलब्ध है।

पैंतीस सेंट. जब आप इसे देखते हैं तो स्लीप नंबर का एक शेयर इतना मूल्यवान होता है - एक कंपनी जिसके समायोज्य बिस्तर लाखों अमेरिकी शयनकक्षों में सोते हैं, एक ब्रांड जिसे आपने हजारों विज्ञापनों में देखा है, अब आपके सोफे पर सिक्कों से भी कम मूल्य का है।

पाँच साल पहले, उसी शेयर की कीमत एक सौ सैंतालीस डॉलर थी। वह कोई गिरावट नहीं है. यह निन्यानबे-दस-आठ प्रतिशत का सफाया है। और बारह जून, 2026 को इसके पीछे की कंपनी ने दिवालियापन के लिए आवेदन किया।

Here is the part nobody tells you. Sleep Number was not killed by a fraud. It was not killed by a failed product, or a scandal, or a pandemic. It was killed by a decision its own board made on purpose, quarter after quarter, in plain sight, with Wall Street cheering them on. Over the last decade, this company spent close to one and a half billion dollars buying back its own stock — much of it with borrowed money. It drove its debt from twenty-four million dollars to nearly nine hundred million. Its chief executive was paid nineteen million dollars in a single year, and retired before the bill came due. When the music stopped, the company owed one-point-two-eight billion dollars, and the whole business was sold for four hundred and fifteen million. The shareholders it spent a fortune buying out got nothing. This is the story of how a profitable company put itself to sleep — and exactly who got paid to do it.

It started, the way a lot of strange American success stories do, with something that sounded like a gimmick. In 1987, in Minnesota, a company called Select Comfort began selling a mattress you could inflate. Not a waterbed — an air bed, with a chamber inside and a dial on the nightstand. You picked a number, from zero to one hundred, and the bed firmed up or softened to match. That number was your Sleep Number.

It should have been a late-night infomercial footnote. Instead, it became a category. Because Select Comfort understood something most mattress makers did not: it sold directly to you. Its own stores, its own showrooms, its own salespeople walking you to a bed and asking you to lie down. By the 2010s there were more than six hundred and fifty of those stores, in malls and strip centers across the country. The company stopped being a curiosity and became a fixture.

In 2017, it made the transformation official. Select Comfort renamed itself after the thing customers actually remembered — Sleep Number. It leaned hard into technology: smart beds that tracked your heart rate, your breathing, your restlessness, and gave you a score every morning. A four-thousand-dollar bed that talked to an app. It was, for a while, a genuinely good business. Real factories. Real engineers. Real customers who loved the product and bought another one for the guest room. Remember that, because it matters. What happened to Sleep Number was not the failure of a bad company. It was a choice made by a good one. And to understand the choice, you have to follow the money — starting with the best two years the company ever had.

When the pandemic sent everyone home in 2020, something unexpected happened to the bed business. People stuck in their houses, staring at the ceiling, suddenly cared a great deal about where they slept. Demand for premium mattresses exploded. Sleep Number's profits spiked. The stock, which had spent years drifting in the forties and fifties, took off — climbing past a hundred dollars, then past a hundred and forty, peaking at a hundred and forty-seven dollars in March of 2021.

A company that lucky has a choice to make with the windfall. It can pay down debt. It can build a cash cushion for the next downturn. It can invest in the next product. Sleep Number did something else. It took the cash — and then borrowed even more — and spent it buying its own stock.

Let me explain what that actually means, because "share buyback" is one of those phrases designed to sound boring. When a company buys back its stock, it takes its own money and purchases its shares off the open market, then retires them. Fewer shares exist. And here is the trick: the company's profits are now divided among fewer slices, so earnings per share — the number Wall Street watches — goes up automatically. The business has not sold a single extra bed. It has not invented anything. But on paper, the stock looks stronger, and the price tends to rise. For executives whose pay is tied to that number, a buyback is the easiest raise in the world.

Sleep Number bought, and bought, and bought. Two hundred and seventy-nine million dollars of its own stock in 2018. Nearly two hundred million in a single quarter at the end of 2020 alone. Three hundred and sixty-four million in just the first nine months of 2021 — buying shares at prices as high as a hundred and forty-seven dollars, the very top. All told, over the decade, close to one and a half billion dollars poured into propping up its own share price. Wall Street applauded every announcement. The board called it returning value to shareholders. And for a while, it looked like genius. But genius and recklessness can look identical right up until the moment they don't — because Sleep Number was not paying for any of this out of a vault of cash. It was paying with a credit card.

This is the part that everyone cheered and nobody stress-tested. Sleep Number did not have one and a half billion dollars of spare money lying around. So to keep buying its stock, it borrowed. Watch the two lines move together. In 2017, the company's long-term debt was just twenty-four and a half million dollars — basically nothing. By 2019, it was five hundred and eighty million. By 2021, seven hundred and ninety million. By 2022, nearly nine hundred million dollars. The debt curve and the buyback curve are not two different stories. They are the same line. The company was borrowing money from lenders to hand to shareholders, and calling it strength.

And the people steering that decision had every reason to keep steering. Executive pay at Sleep Number was tied to metrics like return on invested capital and earnings per share — the exact numbers that buybacks mechanically inflate. Shrink the share count, and the per-share results improve whether the business is healthier or not. In 2021, chief executive Shelly Ibach was paid nineteen million and twenty-five thousand dollars. Her restricted stock paid out at a hundred and sixty-seven percent of target — rewarded for hitting the very goals the buyback program was juicing. Read that again. The board was paying its leadership a premium for running the engine that was quietly hollowing the company out. Everyone inside the room was getting richer. The risk was being shipped to the future, and the future does not get a vote — until it arrives. And it was about to.

There is one number from those years that almost nobody reported at the time. By the end of 2021 — the year the stock peaked at a hundred and forty-seven dollars, the year Ibach was paid nineteen million — Sleep Number's net worth on its own balance sheet was already negative. Not thin. Not stretched. Negative four hundred and twenty-five million dollars. Shareholder equity — everything the company owned, minus everything it owed — had been driven below zero by the buybacks themselves. By the only accounting that counts, the company was already worth less than nothing. And it was still borrowing money to buy back its own stock.

Then the reckoning came, and it came as interest rates. Starting in 2022, the era of free money ended. Borrowing costs jumped. The housing market froze. And a four-thousand-dollar smart bed turned out to be exactly the kind of purchase Americans defer the instant their budgets tighten. You do not need a new bed this year. You can wait. And millions of people did.

Sleep Number's sales began to slide — through 2023, through 2024, through 2025. But the debt did not slide with them. The interest payments came due on schedule, indifferent to how many beds were moving. And the cash cushion that might have carried the company through a soft patch? It was gone. It had been spent — on stock, at the top, that was now worth a fraction of what they paid. The company had traded its safety margin for a higher share price, and now it needed that margin and did not have it.

In 2025, a new chief executive, Linda Findley — who had run Blue Apron — inherited the wreckage. There was not much she could do. The decisions that doomed the company had been made years earlier, by people who were already gone. In May 2026, Sleep Number badly missed its earnings, suspended its financial guidance entirely — a signal to Wall Street that management itself no longer knew where the bottom was — and the stock, once a hundred and forty-seven dollars, slid toward a single dollar. Securities lawyers began circling, opening fraud investigations on behalf of the shareholders left holding the bag. The countdown had started, and there was no version of the math that ended well.

On June twelfth, 2026, it ended. Sleep Number filed for Chapter 11 bankruptcy in the Southern District of New York — case number 26-11399. The filing laid the whole thing bare: one-point-two-eight billion dollars in liabilities, against just six hundred and forty-two million dollars in assets. The stock sat at thirty-five cents.

There was no rescue, no turnaround, no fight to stay independent. The entire company — the brand, the factories, the stores, the smart beds — was sold. The buyer was Sleep Country Canada, owned by the financial conglomerate Fairfax Financial, which stepped in as the stalking-horse bidder for four hundred and fifteen million dollars. Roughly thirty-three cents on every dollar the company owed. Secured lenders took a loss. And the common shareholders — the ordinary investors, the index funds, the employees who held the stock the company had spent a billion and a half dollars buying back — were wiped clean to zero.

Now follow the money out the door. Shelly Ibach, the chief executive through the buyback years, was long gone before the filing — her retirement announced in October 2024, her nineteen-million-dollar year and the years around it safely banked. She did not ride the stock to thirty-five cents. The executives who ran the program got paid for the metrics it produced, and left. The lenders who financed it will be repaid from the sale. And the beds, by the way, still work — the brand survives under its new Canadian owner, the same product on the same showroom floor.

So here is the receipt. Sleep Number was a real company that made a real product millions of people loved. It did not have to die. It borrowed a billion and a half dollars to buy its own stock at the highest prices in its history, enriched the people who made that call, and left no cushion for the downturn that always comes. When it came, the company that had spent a fortune buying its shares discovered those shares were worth nothing — and so were everyone else's. The buybacks were legal. The pay packages were approved. Every box was checked. That is the quiet scandal of it. Nobody had to break the law to turn a healthy company into a thirty-five-cent stock. They just had to keep telling everyone it was strength — right up until the moment the bed deflated.